Elixa Medicaments Private Limited

This company manufactures and distributes pharmaceutical products for various medicinal systems and instruments.

2017 | Kolhapur, Maharashtra (India) | Active
Last Updated:

Elixa Medicaments Profile

Key Indicators

  • Authorised Capital ₹ 4.50 M
  • Paid Up Capital ₹ 1.17 M
  • Company Age 7 Year, 7 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth 82.05%
  • Profit Growth 16.16%
  • Ebitda -304.16%
  • Net Worth 7.13%
  • Total Assets 19.12%

About Elixa Medicaments

Elixa Medicaments Private Limited (EMPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 2017 (Seven years and seven months 12 days old ). Its registered office is in Kolhapur, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 1.17 M, as per Ministry of Corporate Affairs (MCA) records.

Rashmi Deshpande and Rajiv Deshpande serve as directors at the Company.

Company Details

  • Location

    Kolhapur, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U33309PN2017PTC172931

  • Company No.

    172931

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    10 Oct 2017

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Pune

Industry

Pharma
Company report

Elixa Medicaments Private Limited

Explore comprehensive data for Elixa Medicaments Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Elixa Medicaments?

Board Members (2)

NameDesignationAppointment DateStatus
Rashmi Deshpande Country flag representing In Director 10-Oct-2017Current
Rajiv Deshpande Country flag representing In Director 18-Mar-2020Current

Financial Performance of Elixa Medicaments.

Elixa Medicaments Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 82.05% increase. The company also saw a substantial improvement in profitability, with a 16.16% increase in profit. The company's net worth moved up by a moderate rise of 7.13%.

Elixa Medicaments revenue growth over time
Elixa Medicaments profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
82.05%
Revenue from Operations
82.05%
Total Assets
19.12%
Profit or Loss
16.16%
Net Worth
7.13%
EBITDA
-304.16%

What is the Ownership and Shareholding Structure of Elixa Medicaments?

In 2019, Elixa Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Elixa Medicaments?

Unlock and access historical data on people associated with Elixa Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Elixa Medicaments Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elixa Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixa Medicaments's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Elixa Medicaments

Recent activity within the organization

  • Annual General Meeting

    Elixa Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

  • Balance Sheet

    Elixa Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune.

  • Director Appointment

    Rajiv Vijayraj Deshpande was appointed as a Director was appointed as a Director on 18 Mar 2020 & has been associated with this company since 5 years 2 months .

  • Director Appointment

    Rashmi Rajiv Deshpande was appointed as a Director was appointed as a Director on 10 Oct 2017 & has been associated with this company since 7 years 7 months .

  • Company Incorporation

    Elixa Medicaments Private Limited was registered on 10 Oct 2017 with Roc Pune & aged 7 years 7 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Elixa Medicaments Private Limited?

    Elixa Medicaments Private Limited was incorporated on 10 Oct 2017.

  • What is authorized share capital and paid-up capital of Elixa Medicaments Private Limited?

    The authorized share capital of Elixa Medicaments Private Limited is ₹ 4.50 M and paid-up capital is ₹ 1.17 M.

  • Who are the current board members & directors of Elixa Medicaments Private Limited?

    Currently 2 directors are associated with Elixa Medicaments Private Limited.

    • Rashmi Rajiv Deshpande
    • Rajiv Vijayraj Deshpande

  • What is the registered address of Elixa Medicaments Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Elixa Medicaments Private Limited is Csno814/2/1Awingorchidhomesfl.No.104Eward, Karandemala India, Kolhapur, Maharashtra, 416003.

  • What is the corporate identification number (CIN) and company number of Elixa Medicaments Private Limited?

    The corporate identification number (CIN) of Elixa Medicaments Private Limited is U33309PN2017PTC172931 and the company number is 172931 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Elixa Medicaments Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for Elixa Medicaments Private Limited has risen by 82.05%.

  • What change has been observed in the net worth of Elixa Medicaments Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Elixa Medicaments Private Limited has experienced an upsurge of 7.13%.

  • When was the last Balance Sheet of Elixa Medicaments Private Limited filed with the ROC?

    The most recent Balance Sheet for Elixa Medicaments Private Limited was filed with the ROC on 31 Mar 2022.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development